133 related articles for article (PubMed ID: 32308452)
1. Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States.
Kalirai S; Ivanova JI; Perez-Nieves M; Stephenson JJ; Hadjiyianni I; Grabner M; Pollom RD; Geremakis C; Reed BL; Fisher L
Diabetes Metab Syndr Obes; 2020; 13():1023-1033. PubMed ID: 32308452
[TBL] [Abstract][Full Text] [Related]
2. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey.
Perez-Nieves M; Ivanova JI; Hadjiyianni I; Zhao C; Cao D; Schmerold L; Kalirai S; King S; DeLozier AM; Birnbaum HG; Peyrot M
Curr Med Res Opin; 2017 Oct; 33(10):1833-1842. PubMed ID: 28604111
[TBL] [Abstract][Full Text] [Related]
3. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
[TBL] [Abstract][Full Text] [Related]
4. Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from Germany.
Moennig E; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova J; Klask R
Exp Clin Endocrinol Diabetes; 2018 May; 126(5):287-297. PubMed ID: 28895642
[TBL] [Abstract][Full Text] [Related]
5. Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.
Hadjiyianni I; Desai U; Suzuki S; Ivanova JI; Cao D; Kirson NY; Chida D; Enloe C; Birnbaum HG; Perez-Nieves M
Diabetes Ther; 2017 Feb; 8(1):149-166. PubMed ID: 27913984
[TBL] [Abstract][Full Text] [Related]
6. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
[TBL] [Abstract][Full Text] [Related]
7. Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey.
Peyrot M; Perez-Nieves M; Ivanova J; Cao D; Schmerold L; Kalirai S; Hadjiyianni I
Curr Med Res Opin; 2017 Oct; 33(10):1843-1851. PubMed ID: 28604112
[TBL] [Abstract][Full Text] [Related]
8. Basal insulin persistence in Brazilian participants with T2DM.
Franco DR; Perez-Nieves M; Ivanova JI; Cao D; Vaz MSC
Rev Assoc Med Bras (1992); 2019; 65(10):1254-1264. PubMed ID: 31721957
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes.
Melzer-Cohen C; Chodick G; Husemoen LLN; Rhee N; Shalev V; Karasik A
Diabetes Ther; 2019 Apr; 10(2):683-696. PubMed ID: 30815829
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.
Dalal MR; Kazemi M; Ye F; Xie L
Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282
[TBL] [Abstract][Full Text] [Related]
11. Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study.
Allen-Ramey F; Mao J; Blauer-Peterson C; Rock M; Nathan R; Halpern R
Curr Med Res Opin; 2017 Nov; 33(11):2039-2047. PubMed ID: 28737480
[TBL] [Abstract][Full Text] [Related]
12. Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study.
Polonsky W; Gamble C; Iyer N; Martin M; Hamersky C
Diabetes Spectr; 2021 May; 34(2):175-183. PubMed ID: 34149258
[TBL] [Abstract][Full Text] [Related]
13. Barriers to the initiation of, and persistence with, insulin therapy.
Oliveria SA; Menditto LA; Ulcickas Yood M; Koo YH; Wells KE; McCarthy BD
Curr Med Res Opin; 2007 Dec; 23(12):3105-12. PubMed ID: 17977482
[TBL] [Abstract][Full Text] [Related]
14. Changes in patient-reported outcomes between continuers and discontinuers of disease modifying therapy in patients with multiple sclerosis over age 60.
Hua LH; Harris H; Conway D; Thompson NR
Mult Scler Relat Disord; 2019 May; 30():252-256. PubMed ID: 30851638
[TBL] [Abstract][Full Text] [Related]
15. Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens.
Yavuz DG; Ozcan S; Deyneli O
Patient Prefer Adherence; 2015; 9():1225-31. PubMed ID: 26346988
[TBL] [Abstract][Full Text] [Related]
16. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
17. Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US.
Lin J; Lingohr-Smith M; Fan T
Clinicoecon Outcomes Res; 2017; 9():19-29. PubMed ID: 28053550
[TBL] [Abstract][Full Text] [Related]
18. Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interview.
Kamal-Bahl S; Watson DJ; Ambegaonkar BM
Clin Ther; 2009 Jan; 31(1):130-40. PubMed ID: 19243714
[TBL] [Abstract][Full Text] [Related]
19. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
[TBL] [Abstract][Full Text] [Related]
20. Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database.
Beachler DC; Fernandes G; Deshpande G; Jemison J; Lyons JG; Lanes S; Liu J; McNeill A
Curr Med Res Opin; 2018 Jun; 34(6):1061-1069. PubMed ID: 29264933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
